Exalenz's device to diagnose H. pylori bacteria is released

07/16/2013 | Reuters

Exalenz Bioscience said its BreathID Hp device, the latest addition to its BreathID product portfolio, is available commercially. The device uses a patient's breath to detect Helicobacter pylori bacteria, which is often tied to peptic ulcers and may also raise gastric-cancer risk. The test can generate results in 10 to 15 minutes.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN